New Charts & Cellceutix Drug Fights Leukemia!
Stock Market Video Charts – Hot Investment Alerts Newsletter
Stock Market Video Charts Daily Newsletter March 7, 2011 Video Charts for Today Today, video charts are being prepared on:
NGAS Resources, Inc. (NASDAQ:NGAS) Capstone Turbine Corp. (NASDAQ:CPST) High Plains Gas, Inc. (OTCBB:HPGS) All information provided in the video is purely our opinion and is by no means a solicitation to buy or sell any security.
www.StockMarketVideoCharts.com – sure to tell you friends and colleagues to visit us.
Good Morning! I hope that everyone enjoyed their weekend, but now it`s back to business. Today`s charts, once again provide a mix of charts that made a move through resistance and those looking to make a breakout. Cellceutix (OTCQB:CTIX) had a great climb last week and released some incredible news today on its flaghip drug, Kevetrin™, being proven to destroy LEUKEMIA cells! The news will be posted in a matter of moments on SMVC.
QUICK THOUGHTS ON TODAY`S VIDEO CHARTS:
The NGAS stock chart has made a nice climb since its double bottom /
pincher play pattern at the end of last year. On Friday, the share priced moved through some resistance on increased volume and the chart is now on radar for continuation through another resistance level at 65 cents.
The CPST stock chart broke through resistance at $1.55 on Friday on more than double average volume. The chart has been bullish for the last half year and looks like it may be trying to make another bullish push again this week. Technical traders are on alert for continuation of Capstone’s upward momentum.
The HPGS stock chart has been on a steady uptrend for four months now. A low volume play, support is established at $1.10 and the chart appears to be poised to challenge some resistance at $1.30 and even the old high of $1.40 that was reached early in February. If the break north happens, the top of the channel would not be reached until the area of $1.60.
Visit our friends at:
– Corporation is a developmental biotech that is nearing clinical stages with its Cancer drug, Kevetrin. The scientist behind this new cancer drug was also behind the blockbusters, Alimta and Gemzar while at Eli Lilly. Cellceutix also has additional drugs in its pipeline that sets this company apart from many others; big or small. Learn more about Cellceutix at www.otcshowcase.com – and you`ll soon realize why we like this biotech play.
DISCLAIMER:
The disclaimer is to be read and fully understood before using our site or subscribing to our newsletter or viewing the StockMarketVideoCharts website. Please read our FULL disclaimer at .
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE, VIDEOS OR NEWSLETTER. THE VIDEOS PROVIDED AND ANY COMMENTARY ARE FOR ENTERTAINMENT PURPOSES ONLY. ALWAYS CONSULT A QUALIFIED INVESTMENT ADVISOR BEFORE MAKING ANY INVESTMENT DECISIONS.
INVESTING INVOLVES A HIGH DEGREE OF RISK IN WHICH YOU COULD LOSE UP TO 100% OF YOUR INVESTMENT! Neither www.stockmarketvideocharts.com nor its officers, directors, partners, employees or anyone involved in the publication of this website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever.
Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. Past performance of companies profiled on our website is not indicative of future results. Nothing on the website or in this newsletter is an endorsement or solicitation to buy or sell any security in any way, shape or form. We are not qualified in any sense to provide recommendations or advice. Some companies profiled within this website and/or newsletters may lack a liquid trading market for their securities and investing in such securities is highly speculative and carries a high degree of risk. Never invest in any security featured on our website or newsletters unless you can afford to lose your entire investment.Occassionally, we will have a featured or sponsored video as part of the newsletter. We may or may not have been compensated to create the video chart. As such, this creates a conflict of interest in our ability to remain unbiased in commentary.
Through use of our website and newsletter, you agree to hold us harmless and to completely release us from any and all liability due to any and all loss, damage, or injury, monetary or otherwise, that you may incur.To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided on this website or in any company profile, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).
Investing in securities is speculative and carries serious risk. No investment should be made unless you can afford to lose your entire investment. It is possible that an investor`s entire investment may be lost or impaired due to the speculative nature of the companies mentioned. ALWAYS consult an investment adviser or broker-dealer before purchasing or selling any securities viewed on or mentioned on this website or our newsletters. Invest at your own risk.
Information contained on our website or in the company profiles will contain “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as “expects,” “will,” “anticipates,” “estimates,” “believes,” or statements indicating certain actions “may,” “could,” or “might” occur.
It is possible that some of the companies listed within our videos, articles, newsletters, alerts or on a section of our website may have compensated us to be profiled. These companies (or affiliates) have retained us to perform public relations, or media relations or even investor relation services including promotional services that consist of the placement of the profiled companies on our website or newsletters to our subscribers. If compensation has been received, we will comply with the full disclosure requirements as outlined in RULE 17(b) Section 17(b) of the 1933 Act, which provides that it is unlawful for any person: “to publish, give publicity to, or to circulate any notice, circular, or advertisement, newspaper article, letter, investment service, or communication which, though not purporting to offer a security for sale, describes such security for a consideration received or to be received, directly or indirectly, from an issuer, underwriter or dealer, without fully disclosing receipt, whether past or prospective, of such compensation and the amount thereof.” The specific compensation type and amounts that we have been paid from each respective client company will be provided in detail within each email newsletter and/or disclosure portion of our website.
Viper Enterprises LLC, the parent company of StockMarketVideoCharts.com, has been compensated 50,000 restricted shares for investor and public relations duties by Cellceutix Corporation. Viper Enterprises LLC, the parent company of StockMarketVideoCharts.com, has been compensated 50,000 restricted shares for investor and public relations duties by BioMedical Technology Solutions Holdings, Inc. Viper Enterprises has been compensated three hundred and fifty dollars for the production and dissemination of the video chart presentation of Southern Home Medical Equipment, Inc. by a third party. While we typically will not accept free trading shares for compensation, it is possible that others are selling shares into the market. In any case, compensation received, in the form of shares or cash, can be construed as a conflict of interest in formation of our opinions and must be duly noted by the readers of this website.
Email: admin@stockmarketvideocharts.com ______________________________________________________________________ Click to view this email in a browser
Related posts:
- Crunching Bohai’s Numbers- Value Still Swelling, Target Still Rising
- MovingPennies.com – Our New Alert is $GUGO
- GRHU to Implement Southern California Edison’s Automated Demand Response
- Does Egypt Drama Mean More IPRC Profits?
- AFFW – Affinity Mediaworks Is our New Alert that Is sure To add to your Prtfolio net worth